Citius Pharmaceuticals, Inc. (CTXR) Gross margin 2017–2019
Citius Pharmaceuticals, Inc. (CTXR) gross margin by fiscal year — reported gross profit divided by reported revenue.
16.7%FY2019 · since FY2017: 10.0% → 16.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 16.7% | -16.7 pp |
| FY2018 | 33.3% | +23.3 pp |
| FY2017 | 10.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR RevenueCTXR Net incomeCTXR Net marginCTXR Gross profitCTXR Operating incomeCTXR Operating marginCTXR Operating cash flowCTXR Free cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total assetsCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →